大连雅思考试试题

大连雅思考试试题

　　无论是在学校还是在社会中，我们总免不了要接触或使用试题，试题可以帮助主办方了解考生某方面的知识或技能状况。你知道什么样的试题才是好试题吗？以下是小编整理的大连雅思考试试题，仅供参考，希望能够帮助到大家。

　　L--V67

　　R--V66

　　W--V115

　　听力V67回忆

　　section 1 印度女生的accommodation form second name(Bhatt)，生日(31 March 1972)，住几年(2)，住宿类型(bedside)，爱好，习惯(no red meat)，和谁住(student)，有什么要求(有shared room)

　　section 2 picture和movie

　　7——8道选择题3选1，第一道是图中马的几条腿离地？

　　还有谁问发明的什么玩意儿？

　　然后3-4个填空问有一部电影是什么？

　　还有一部电影地意思用了什么填声音什么的？

　　还有一个电影第一次用了subtitle因为(sound bad)

　　section3 是一个表格，好像是教授问两个学生一男一女，

　　答案上下左右次序挺乱，有爱好什么的，

　　section4 先是填空将学校的设施在什么位置等，

　　然后是地图，让你在7-8各选项中选出4个填在空著名称的建筑上。

　　Reading

　　第一篇就是V25的第一篇！关于rhythm。

　　阅读第二篇讲阿拉斯加捕鱼业

　　第三篇讲语言变化，有可能是V27的SECTION3

　　都比第一篇简单些。

　　writing V115

　　Task 1

　　关于2000年，英国的犯罪率，两个图，第一个根据年龄的曲线图，第二个是pie chart.是关于囚犯性别的，女4%，男96%。

　　Task 2

　　有人认为不应该杀动物，因为那是残忍和不必要的，有人认为肉类是必要的，谈一下这两方面和你的观点。

　　Some people think killing animals for food is cruel and unnecessary and some people think is essential for dairy diet ...To extend what do you think about the both issues?

　　试题二

　　1. The failure of a high-profile cholesterol drug has thrown a spotlight on the complicated machinery that regulates cholesterol levels. But many researchers remain confident that drugs to boost levels of ’good’ cholesterol are still one of the most promising means to combat spiralling heart disease.

　　2. Drug company Pfizer announced on 2 December that it was cancelling all clinical trials of torcetrapib， a drug designed to raise heart-protective high-density lipoproteins (HDLs)。 In a trial of 15000 patients， a safety board found that more people died or suffered cardiovascular problems after taking the drug plus a cholesterol-lowering statin than those in a control group who took the statin alone.

　　3. The news came as a kick in the teeth to many cardiologists because earlier tests in animals and people suggested it would lower rates of cardiovascular disease. There have been no red flags to my knowledge， says John Chapman， a specialist in lipoproteins and atherosclerosis at the National Institute for Health and Medical Research (INSERM) in Paris who has also studied torcetrapib. This cancellation came as a complete shock.

　　4. Torcetrapib is one of the most advanced of a new breed of drugs designed to raise levels of HDLs， which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body. Specifically， torcetrapib blocks a protein called cholesterol ester transfer protein (CETP)， which normally transfers the cholesterol from high-density lipoproteins to low density， plaque-promoting ones. Statins， in contrast， mainly work by lowering the ’bad’ low-density lipoproteins.

　　Under pressure

　　5. Researchers are now trying to work out why and how the drug backfired， something that will not become clear until the clinical details are released by Pfizer. One hint lies in evidence from earlier trials that it slightly raises blood pressure in some patients. It was thought that this mild problem would be offset by the heart benefits of the drug. But it is possible that it actually proved fatal in some patients who already suffered high blood pressure. If blood pressure is the explanation， it would actually be good news for drug developers because it suggests that the problems are specific to this compound. Other prototype drugs that are being developed to block CETP work in a slightly different way and might not suffer the same downfall.

　　6. But it is also possible that the whole idea of blocking CETP is flawed， says Moti Kashyap， who directs atherosclerosis research at the VA Medical Center in Long Beach， California. When HDLs excrete cholesterol in the liver， they actually rely on LDLs for part of this process. So inhibiting CETP， which prevents the transfer of cholesterol from HDL to LDL， might actually cause an abnormal and irreversible accumulation of cholesterol in the body. You’re blocking a physiologic mechanism to eliminate cholesterol and effectively constipating the pathway， says Kashyap.

　　Going up

　　7. Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients. But HDLs are complex and not entirely understood. One approved drug， called niacin， is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling. Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone. Scientists are also working on several other means to bump up high-density lipoproteins by， for example， introducing synthetic HDLs. The only thing we know is dead in the water is torcetrapib， not the whole idea of raising HDL， says Michael Miller， director of preventive cardiology at the University of Maryland Medical Center， Baltimore.

　　(613 words nature)

　　Questions 1-7

　　This passage has 7 paragraphs 1-7.

　　Choose the correct heading for each paragraph from the list of headings below.

　　Write the correct number i-ix in boxes 1-7 on your answer sheet.

　　List of Headings

　　i. How does torcetrapib work?

　　ii. Contradictory result prior to the current trial

　　iii. One failure may possibly bring about future success

　　iv. The failure doesn’t lead to total loss of confidence

　　v. It is the right route to follow

　　vi. Why it’s stopped

　　vii. They may combine and theoretically produce ideal result

　　viii. What’s wrong with the drug

　　ix. It might be wrong at the first place

　　Example answer

　　Paragraph 1 iv

　　1. Paragraph 2

　　2. Paragraph 3

　　3. Paragraph 4

　　4. Paragraph 5

　　5. Paragraph 6

　　6. Paragraph 7

　　Questions 7-13

　　Match torcetrapib，HDLs，statin and CETP with their functions (Questions 8-13)

　　Write the correct letter A， B， C or D in boxes 8-13 on your answer sheet.

　　NB You may use any letter more than once.

　　7.It has been administered to over 10，000 subjects in a clinical trial.

　　8.It could help rid human body of cholesterol.

　　9.Researchers are yet to find more about it.

　　10. It was used to reduce the level of cholesterol.

　　11. According to Kashyap， it might lead to unwanted result if it’s blocked.

　　12. It produced contradictory results in different trials.

　　13. It could inhibit LDLs.

　　List of choices

　　A. Torcetrapic

　　B. HDLS

　　C. Statin

　　D. CETP

　　(by Zhou Hong)

　　Suggested Answers and Explanations

　　1. vi

　　2. ii

　　3. vii 本段介绍了torcetrapib和statin的治病原理，但是同时短语in contrast与之前第二段后半段的内容呼应，暗示了这两种药在理论上能相辅相成，是理想的搭配。第一个选项无法涵盖整段意义，故选择i是错误的。

　　4. iii 本段分析了可能导致torcetrapibl临床试验失败的原因，后半段指出如果以上推测正确，那么未来的药物可借鉴这个试验，设法避免torcetrapib的缺陷，研制出有效的药物。viii选项无法涵盖后半段的意思。

　　5. ix 见首句。

　　6. v

　　7. A 见第二段。题目中administer一词意为用药，subject一词为实验对象之意。

　　8. B 见第四段… to raise levels of HDLs， which ferry cholesterol out of artery- clogging plaques to the liver for removal from the body.即HDLs的作用最终是将 choleserol清除出人体：… for removal from the body。

　　9. B 见第四段But HDLs are complex and not entirely understood.

　　10. C 见第二段… plus a cholesterol-lowering statin，即statin是可以降低cholesterol的。

　　11. D 见第六段 So inhibiting CETP， … might actually cause an abnormal and irreversible accumulation of cholesterol in the body.

　　12. A 见第三段。

　　13. C 见第四段Statins， in contrast， mainly work by lowering the ’bad’ low-density lipoproteins.

【大连雅思考试试题】相关文章：

2月8日大连雅思考试试题05-01

雅思考试写作试题荟萃05-04

2011大连中考数学试题04-27

2011大连中考化学试题04-27

雅思考试题第一套Reading05-04

雅思考试题第一套Listening05-04

2011大连中考英语试题及答案04-27

雅思考试阅读考试题类型和备考制胜策略05-04

2011大连中考数学试题答案04-27